21 CFR Part 820 · Quality System Regulation (before Feb 2, 2026)

21 CFR 820.5

Quality system

21 CFR 820.5 is the regulation titled “Quality system” in 21 CFR Part 820, Quality System Regulation (before Feb 2, 2026). Since 2021, 2 FDA warning letters have cited it.

FDA's Quality Management System Regulation reserved this section number on February 2, 2026. These letters cite the earlier Quality System Regulation section, Quality system.

Letters citing it
2 since 2021
Jan 1 to Oct 30, 2026
1 against 1 on the same dates in 2025
Most often cited with
21 CFR 803.17, in 2 letters
Closed out
0% of these letters have a published close-out
See the 2 letters citing 21 CFR 820.5 →

Letters citing it, by year issued

All are medical device letters. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 02022
  3. 02023
  4. 02024
  5. 12025
  6. 12026

What FDA writes when it cites it

The finding headings that cite 21 CFR 820.5 most often, as written in the letters.

  • 2 lettersFailure to establish and maintain a quality system that is appropriate for the specific medical devices designed and manufactured as required by 21 CFR 820.5

The regulation

The text of this section is not in the saved copy.

Text from eCFR.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 820.5.

Latest letters citing it

The 2 letters citing 21 CFR 820.5 that FDA posted most recently.

See the 2 letters citing 21 CFR 820.5 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.